Invenomic Capital Management’s MarketAxess Holdings MKTX Stock Holding History

Invenomic Capital Management’s Portfolio MKTX Stock Details MKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3M	Buy	+90,441	New	+$12.9M	0.61%	56

Other funds holding MKTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

NRCM

North Reef Capital Management Laguna Beach, California $2.61B AUM 11.5% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Invenomic Capital Management's MKTX Position: Q2 2026 in Review

Invenomic Capital Management opened a new position in MarketAxess Holdings (MKTX) in Q2 2026: 90,441 shares worth $10.3M. The stake represents 0.61% of the portfolio and ranks #56 among its holdings.

393 funds tracked by Wall St. Rank hold MKTX as of Q2 2026.

Invenomic Capital Management held 90,441 shares of MarketAxess Holdings worth $10.3M as of Q2 2026.
MarketAxess Holdings was a new Invenomic Capital Management position in Q2 2026.
MarketAxess Holdings made up 0.61% of Invenomic Capital Management's portfolio in Q2 2026, its #56 holding.
393 funds tracked by Wall St. Rank held MarketAxess Holdings as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.